BREYANZI

Welcome to the Brand page for “BREYANZI”, which is offered here for Pharmaceutical preparations for the treatment of cancer and auto-immune diseases; pharmaceutical preparations for the treatment of lymphoma; pharmaceutical preparations for inhibiting cytokine production; pharmaceutical preparations that modulate the immune system; cells for medical or clinical use; diagnostic kits consisting primarily of cells for medical or clinical use;.

Its status is currently believed to be active. Its class is unavailable. “BREYANZI” is believed to be currently owned by “Juno Therapeutics, Inc.”